Because time makes all the difference...
The BD GeneOhm™ MRSA test is the first rapid, molecular-based assay cleared by the FDA, Health Canada and bearing the CE Mark for the direct detection of methicillin- resistant Staphylococcus aureus (MRSA) from a nasal specimen. Test procedure time for the assay is under two hours. Compared to culture methods requiring two to five days, this rapid turn-around time can be used to enhance any infection control program. The test provides a definitive result in a single assay.
The BD GeneOhm™ MRSA test enables hospitals to dramatically improve the identification of MRSA, which can effectively result in the prevention and control of MRSA infections.
- Rapid turnaround time
- Clinical performance
- Can help to dramatically reduce healthcare costs
- Simple use directly from nasal swab
- Adaptable and easily incorporated into existing lab workflow